Annual Revenue ($)

Biogen revenue was $13.44 b in FY, 2020

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019FY, 2020
Revenue$12.27 b$13.45 b$14.38 b$13.44 b
Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020
Revenue$2.81 b$3.08 b$3.08 b$3.13 b$3.36 b$3.44 b$3.49 b$3.62 b$3.6 b$3.53 b$3.68 b$3.38 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Biogen revenue breakdown by business segment: 15.9% from Anti-CD20 Therapeutic Programs, 79.1% from Product Revenues and 4.9% from Other

FY, 2017FY, 2018FY, 2019
Anti-CD20 Therapeutic Programs1.56 b1.98 b2.29 b
Product Revenues10.35 b10.89 b11.38 b
Other360 m585.9 m707.7 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu